TRCT
DBD icon

Tower Research Capital (TRC)’s Diebold Nixdorf DBD Stock Holding History

Tower Research Capital (TRC)’s Portfolio DBD Stock Details DBD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$84.8K Sell
998
-938
-48% -$75.4K ﹤0.01% 2315
2026
Q1 		$146K Buy
1,936
+1,272
+192% +$93.6K ﹤0.01% 1870
2025
Q4 		$45.1K Sell
664
-544
-45% -$34K ﹤0.01% 2502
2025
Q3 		$68.9K Sell
1,208
-3,737
-76% -$221K ﹤0.01% 2275
2025
Q2 		$274K Buy
4,945
+4,441
+881% +$208K 0.01% 1504
2025
Q1 		$22K Buy
504
+217
+76% +$9.46K ﹤0.01% 2868
2024
Q4 		$12.4K Buy
287
+182
+173% +$8.2K ﹤0.01% 3622
2024
Q3 		$4.69K Buy
+105
New +$4.34K ﹤0.01% 4449
2024
Q2 		– Sell
-7,459
Closed -$257K – 5734
2024
Q1 		$257K Buy
7,459
+5,864
+368% +$188K 0.01% 1251
2023
Q4 		$46.2K Buy
+1,595
New +$36.4K ﹤0.01% 3187

Other funds holding DBD

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MCM
Millstreet Capital Management Boston, Massachusetts $368M AUM 57.36% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Tower Research Capital (TRC)'s DBD Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its Diebold Nixdorf (DBD) stake by 48% in Q2 2026, selling an estimated $75.4K and leaving 998 shares worth $84.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2315.

Tower Research Capital (TRC) first reported a position in DBD in Q4 2023 and has held it in 10 quarters since. The position peaked at $274K in Q2 2025. 216 funds tracked by Wall St. Rank hold DBD as of Q2 2026.

  • Tower Research Capital (TRC) held 998 shares of Diebold Nixdorf worth $84.8K as of Q2 2026.
  • Tower Research Capital (TRC) sold 938 Diebold Nixdorf shares in Q2 2026, an estimated $75.4K.
  • Diebold Nixdorf made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #2315 holding.
  • Tower Research Capital (TRC) first reported a position in Diebold Nixdorf in Q4 2023 and has held it in 10 quarters since.
  • Tower Research Capital (TRC)'s Diebold Nixdorf position peaked at $274K in Q2 2025.
  • 216 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.